Zhejiang Conba Pharmaceutical Co., Ltd. Class ASSE: 600572

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 16, 2026 · Issued by Zhejiang Conba Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Conba Pharmaceutical Co., Ltd. Class A

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Completion of Filing of Industrial and Commercial Registration Changes for the Transfer of 100% Equity Interest in Dongyang CONBA through Public ListingSep 1
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Key Operating Data for the First Half of 2026Aug 26
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Progress in Public Listing for Transfer of 100% Equity in Dongyang Kang'enbei Printing and Packaging Co., Ltd.Aug 18
"Zhejiang CONBA Pharmaceutical Co., Ltd."Indicative Announcement on the Restricted Exercise Period under the 2022 Stock Option Incentive PlanAug 5

All Zhejiang Conba Pharmaceutical Co., Ltd. Class A news releases